Brain MRI surveillance for stage IV breast cancer
Part of Cancer, Skin clinical trials.
This trial tests whether regular brain MRI scans can help detect brain metastases early in patients with stage IV breast cancer who do not yet have any known brain metastases. The goal is to see if early detection improves outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have stage IV breast cancer that has spread outside the brain.
- You have been diagnosed or started your first treatment for stage IV breast cancer within the last 60 days. If you have HR+/HER2- breast cancer, you may also qualify if you started second-line therapy within 60 days.
- You are at least 18 years old.
- Your doctor expects you to live at least 6 months.
- You are in generally good health (able to do daily activities) and do not have a history of brain metastases, other active cancers, or conditions that make MRI unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether regular brain scans (surveillance) help spot brain metastases early in people with HER2-positive breast cancer that has spread to other parts of the body. Participation involves being randomly assigned to either routine brain scans or no extra scans to see which approach is better.
This trial checks the brain using MRI in people with breast cancer that has spread outside the breast or can’t be fully removed. The goal is to screen for brain involvement and see how MRI findings fit with treatment timing, when it’s safe to do so.
This trial uses an MRI scan to look for early signs of breast cancer spreading to the brain in people with certain aggressive breast cancer types (triple-negative or HER2-positive) that are stage IIb or III. The goal is to find and treat brain metastases earlier, before they cause symptoms.
This study looks at factors that affect survival in breast cancer patients whose cancer has spread to the brain. The goal is to learn more about what influences outcomes, which may help guide future treatment decisions.
This trial tests a new type of whole-brain radiotherapy that avoids the hippocampus (a brain area important for memory) in people whose breast cancer has spread to the brain. It is for those who cannot have the focused kind of radiation (stereotactic radiotherapy) and might help preserve memory while treating the tumors.
This Phase 2 study tests a treatment for people with triple-negative breast cancer that has spread to the brain. It’s designed for situations where the cancer can’t be safely cured with surgery or focused radiation.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.